National Bowel Cancer Audit Annual Report 2019

Reports | Published: 09 Jan 2020

The 2019 Annual Report is the tenth report to date and includes data on over 30,000 patients diagnosed with bowel cancer between 01 April 2017 and 31 March 2018.

For the first time, new indicators of return to theatre and robotic surgery are reported and the measure of adjuvant chemotherapy for stage III colon cancer is reported at trust/hospital level in England. The report discusses several key findings for care pathways, surgical care, survival, rectal cancer and National Cancer Registry data.

15.01.2020: Version 2 – We have re-issued the 2019 NBoCA Annual report (published on 09/01/2020) to correct the labelling on the Figure 3.3 legend (p18) from ‘mortality rate’ to ‘resection rate’ for both England and Wales.  We regret the original report contained this error and apologise for any inconvenience this may have caused.  The report conclusions and recommendations are unchanged.

You can download the report here.

Stay-up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.

Don’t miss out. Sign up to be notified when this resource is updated and to receive updates about other related quality improvement resources, events and news from HQIP. Or you can  .

By continuing you agree to receive emails with updates and other information from HQIP and you are confirming you are over the age of 13.

Please read our privacy policy to understand how HQIP uses the information you provide, your use of HQIP’s website and your interaction with the marketing emails to improve the relevance of the communications we send you. You can unsubscribe at any time.

I have read and agree with the contents of the privacy policy.

National Bowel Cancer Audit Annual Report 2019